Friday 23 October 2020
The German medical technology group Siemens Healthineers takes another big step with the acquisition of US cancer specialist Varian. In the US, the Federal Trade Commission (FTC) approved the $ 16.4 billion acquisition, as the Siemens subsidiary announced. In addition to this antitrust approval in this important market, Siemens Healthineers requires approvals in other countries. The Group continues to expect the transaction to be completed in the first half of 2021.